Stanford scientists 'totally surprised' by potential Parkinson's treatment discovery
The research, published in the journal Science Signaling, took a closer look at enzymes — proteins in the body that speed up chemical reactions and are essential for digestion, liver function and other key functions, according to Cleveland Clinic — and their role in Parkinson's.
The team found that targeting a certain enzyme helped to restore neuron and cell communication in mice.
Music Conductor With Parkinson's Sees Symptoms Improve With Deep Brain Stimulation
Lead author Suzanne Pfeffer, PhD, the Emma Pfeiffer Merner Professor in Medical Sciences and a professor of biochemistry at Stanford, told Fox News Digital that the team was "totally surprised that we saw as much improvement as we did."
In about 25% of Parkinson's cases, the culprit is some form of genetic mutation. One of the most common mutations creates an overactive enzyme called LRRK2, according to a Stanford press release.
Read On The Fox News App
When there is too much LRRK2 activity, it changes the structure of the brain cells, disrupting important communication between neurons and cells. This system is crucial to movement, motivation and decision-making, according to the researchers.
The goal of the study was to determine whether a specific molecule — the MLi-2 LRRK2 kinase inhibitor — could reverse the effect of overactive enzymes.
Parkinson's Patients Who Take 'Magic Mushrooms' See Key Benefits, Study Finds
Using mice that had the genetic mutation that causes overactive LRRK2 and also had symptoms consistent with early Parkinson's disease, the scientists tried feeding them the inhibitor for two weeks.
There were initially no changes detected in brain structure, signaling or function of the dopamine neurons.
However, after three months of eating the inhibitor, mice affected by the overactive enzyme appeared to have restored their neurons to the point where they were virtually the same as those without the genetic mutation, the study found.
"Findings from this study suggest that inhibiting the LRRK2 enzyme could stabilize the progression of symptoms if patients can be identified early enough," Pfeffer said in the press release.
The study did have some limitations, the researchers acknowledged.
"This was in mice, not people, but our current results indicate that similar pathways are important in humans," Pfeffer told Fox News Digital.
While the study focused on a specific genetic form of the disease, overactive LRRK2 is also present in other cases, meaning this treatment could help multiple types of Parkinson's patients and possibly those with other neurodegenerative diseases, the reseachers claimed.
Looking ahead, the team plans to investigate whether other forms of Parkinson's could benefit.
Click Here To Sign Up For Our Health Newsletter
Parkinson's — a disease that involves the slow death of dopamine-producing neurons, leading to symptoms like tremors and stiffness — affects nearly one million Americans, according to the Parkinson's Foundation, which has offices in New York and Miami.
Experts agree that early intervention is key, as Parkinson's symptoms often appear years after the disease begins.
Identifying and treating at-risk individuals sooner could potentially halt or reverse neuron loss.
"These findings suggest that it might be possible to improve, not just stabilize, the condition of patients with Parkinson's disease," Pfeffer said.
For more Health articles, visit www.foxnews.com/health
The researcher told Fox News Digital that it's important to encourage patients to undergo genetic testing to learn more about their suitability for clinical trials and future treatments.
The study was funded by The Michael J. Fox Foundation for Parkinson's Research, the Aligning Science Across Parkinson's initiative and the United Kingdom Medical Research Council.Original article source: Stanford scientists 'totally surprised' by potential Parkinson's treatment discovery
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Fox News
4 hours ago
- Fox News
Should you try hypnosis to stop drinking? Here's what the experts say
While some people may be skeptical of hypnosis, experts say it's a legitimate therapy that can help with a range of physical and mental challenges — including, possibly, alcohol use disorder. Clinical hypnosis has shown to be effective in the treatment of pain, anxiety, stress, cancer treatment side effects, phobias and habit control problems, such as smoking and weight control, according to past randomized controlled trials. "Hypnosis is the oldest Western form of psychotherapy, but it is underutilized," Dr. David Spiegel, associate chair of psychiatry at Stanford University School of Medicine in California and a leading authority in the field of hypnosis, told Fox News Digital. Hypnosis is not itself considered a therapy. Rather, it enhances other treatments by inducing a state of increased concentration while reducing peripheral awareness, experts say. The practice aims to put people in a deep state of relaxation so they can learn more easily. Shawn Criswell, Ph.D., a mental counselor practicing in Oregon, defines it as "a gentle way of shifting people's focus to new ideas and perspectives that can help improve their lives." Added Criswell, "It does this in part by connecting them with their strengths and resources, empowering them in the process, and directly contradicting the old, tired myth that in hypnosis, you'll give up control of yourself." He co-authored, together with Michael Yapko, Ph.D, the latest edition of "Trancework: An Introduction to the Practice of Clinical Hypnosis." Past research suggests that hypnosis may alter brain activity related to attention and consciousness. "The brain activation patterns during hypnosis — such as for color, pain and sound — are similar to those observed during actual experiences," Dr. Ryan Sultan, attending physician at NewYork-Presbyterian Hospital and director of the Mental Health Informatics Lab at Columbia University Irving Medical Center, told Fox News Digital. Some people may choose to practice self-hypnosis, which he described as the process of entering a trance-like state without the guidance of a hypnotist. Sultan compared it to entering a "controlled, simplified state" in which people may be more open to certain ideas and therapeutic suggestions. "I have had patients stop drinking by focusing on respecting and protecting their bodies." But the effects can be short-lived, he noted, and some individuals may find it difficult to maintain the hypnotic state without external cues. The treatment technique has been approved by the American Psychiatric Association and the American Psychological Association. To maximize its safety and effectiveness, Sultan recommended hypnosis by a qualified professional. Hypnosis may help support people with drinking problems by encouraging motivation, reducing cravings and helping to manage stress, according to Dr. Lama Bazzi, a psychiatrist in private practice in New York City. The expert emphasized, however, that hypnosis is not a standalone cure for problem drinking. Instead, it's part of a comprehensive treatment plan that includes focused cognitive-behavioral therapy, psychiatric support and targeted medications when necessary. "There is less evidence about alcohol problems, but I have had patients stop drinking by focusing on respecting and protecting their bodies," Spiegel noted. "One of my patients thought about that concept in hypnosis, and said, 'You mean, the body is the temple of the soul?'" he added. Hypnotherapy presents little risk, according to Spiegel. "The worst thing that can happen is that it may not always work," he told Fox News Digital. "It is best to seek care from a psychiatrist or psychologist with specialized training in clinical hypnosis." Possible mild side effects include dizziness and emotional release. There is also a risk of false memories if used for memory recall, Sultan cautioned. The therapy is also not recommended for people with severe mental illness, such as psychosis, experts say. Mayo Clinic also notes that side effects are uncommon, but that some people may experience anxiety, sleepiness, headache and nausea. "It is best to seek care from a psychiatrist or psychologist with specialized training in clinical hypnosis," Bazzi told Fox News Digital. "These professionals can objectively assess your susceptibility to hypnosis, determine whether it is an appropriate and potentially effective intervention for your specific concerns, and develop a comprehensive, multimodal treatment plan tailored to your needs," she added. For those seeking a hypnotist, experts recommend visiting the websites of the American Society of Clinical Hypnosis or The International Society of Hypnosis, both of which offer directories of professionals who have expertise and often certification in the practice. Some 28 million Americans aged 18 and older are living with alcohol-use disorder, according to 2023 estimates from the National Survey on Drug Use and Health. For more Health articles, visit People may be drinking excessively if they consume enough alcohol in one sitting to raise their blood alcohol level to greater than 0.08, or if they drink more than a certain number of drinks in one week, experts say. This generally equates to women having four or more drinks or men consuming five or more drinks at once — or a weekly amount of eight or more drinks for women or 15 or more drinks for men, according to the Centers for Disease Control and Prevention. Signs of an alcohol problem include experiencing a loss of control when drinking, continuing to drink despite adverse consequences, and experiencing compulsive cravings when not drinking – often referred to as the "three Cs." Those who think they may have an alcohol-dependence problem and are interested in seeking alternative therapies should contact their doctor for recommendations.
New York Post
5 hours ago
- New York Post
Shark bites beach fisherman who dragged thrashing predator back to water after catch
A fisherman in a wealthy beach vacation hot spot became the object of nature's wrath while wrestling with a shark he caught during the July Fourth weekend. A 21-year-old man in Nantucket caught a common sandbar shark on Sunday and reeled it onto shore, according to the Nantucket Current. Advertisement When he attempted to return the shark to the ocean, it bit him on the leg, causing a serious injury. The unnamed victim was driven by friends to a local hospital, and later flown by Boston Medflight helicopter to a mainland hospital to be treated further for his injuries. As the summer beach season is in full effect nationwide, instances of shark bites are increasingly being reported. On the same day as the Nantucket incident, a 40-year-old surfer named Matthew Bender of Winter Park, Florida, was attacked by a shark in New Smyrna Beach, Florida. Benton suffered a 10-inch bite that severed muscles, tendons and nerves, but survived the attack. Advertisement New Smyrna Beach is known as the 'shark bite capital' of the United States, according to 'Shark Week' host Forrest Galante, who recently spoke with Fox News Digital about summer safety tips for avoiding negative encounters with sharks. 3 A fisherman in Nantucket was bit by a shark during the July Fourth weekend. Chris – On June 11, a 9-year-old girl snorkeling off the coast of Boca Grande, Florida, on the state's Gulf Coast, sustained a gruesome shark bite that nearly severed her hand. Leah Lendel was rushed by helicopter to Tampa General Hospital, where she underwent a successful surgery involving artery grafts, bone reconstruction and nerve repair to save her hand. Advertisement Later in June, a beachgoer was injured in an attack on Hilton Head Island, South Carolina, another popular tourist destination for summer getaways. 3 The victim was seriously injured when the shark bit him on the leg. Bokicbo – 3 New Smyrna Beach is known as the 'shark bite capital' of the US. Tropicalens – That incident 'involved a patient with a leg injury consistent with lacerations typically associated with a shark bite,' according to Hilton Head Fire Rescue. Advertisement Galante warned that the ocean is a shark's domain. 'Now, a lot of people fear them, and they see them as mindless killing machines, but the truth is, these are just animals that sit at the top of the food chain,' he said. 'And any time that we enter into the water, we're entering into their domain. So, when there is a shark attack or a shark bite, that is simply because we have gone into a habitat where we as human beings don't really belong, and we're not the apex predator.'
Yahoo
14 hours ago
- Yahoo
Robotic surgery hits 'milestone' with autonomous gallbladder removal
ST. PAUL, Minn., July 9 (UPI) -- Efforts to train robots to perform certain kinds of surgical procedures without human help have reached a "critical milestone" with successful gallbladder removal procedures in lifelike settings, researchers reported Wednesday. Medical robotics experts at Johns Hopkins and Stanford universities revealed in a new study they have "significantly" pushed the envelope on what is possible for robots to do in the operating room without human doctors at the controls, using artificial intelligence to teach them how to overcome unexpected obstacles during surgical procedures. The study, published Wednesday in the journal Science Robotics, described how by using a newly developed AI platform called Surgical Robot Transformer-Hierarchy, or SRT-H, scientists were able to instruct robotic arms to perform eight ex vivo gallbladder procedures "with 100% accuracy" -- all completely autonomously with no human help. SRT-H is the latest advancement in "computer vision," a field of AI that enables robots to "see" and interpret images and videos, much like humans do. The system was shown videos of human surgeons doing the same procedure on pigs and reinforced with natural language captions describing the tasks. It also can respond to human voice commands during procedures. Most significantly, SRT-H showed an ability to self-correct when scientists threw it curve balls such as adding blood-like dyes that changed the appearance of the gallbladder and surrounding tissues. They reported it was still able to precisely perform tasks such as strategically placing clips and severing parts with scissors. The results were deemed important because they appear to move medical science closer to the goal of making AI-powered robots reliable enough for "surgical autonomy," especially in routine procedures such as gallbladder removals, which are performed hundreds of thousands of time each year. The study was led by medical roboticist Axel Krieger, an associate professor at JHU's Whiting School of Engineering, who in 2022 used an earlier AI-based system to autonomously perform the first small-incision, camera-guided surgical procedure on the soft tissue of a pig. SRT-H "represents a fundamental shift from robots that can execute specific surgical tasks to robots that understand surgical procedures," Kreiger told UPI in emailed comments. It makes several key technological advances, including eliminating the requirement that robots operate only on specially marked tissue within highly controlled environments. "The SRT-H adapts to individual anatomical features in real-time, making decisions on the fly and self-correcting when things don't go as expected -- much like a human surgeon would," he said. Also, because the system was built using the same machine learning architecture that powers ChatGPT, it allows the robot to be interactive. "it can respond to spoken commands like 'grab the gallbladder head' or corrections like 'move the left arm a bit to the left,' and actually learn from this feedback during the procedure," Krieger said. The researcher added the learning framework "trains the robot by watching videos of surgeries, similar to how medical students learn. This approach has proven robust enough that the robot performed unflappably across trials with the expertise of a skilled human surgeon, even during unexpected scenarios typical in real surgeries." Other medical robotics experts contacted by UPI agreed the results are a notable achievement for the surgical robotics field but cautioned it's still a long road until the day the machines are deemed safe enough to operate autonomously on human patients. Tamas Haidegger, a professor at Óbuda University in Budapest, Hungary, and technical lead of medical robotics research at its Antal Bejczy Center for Intelligent Robotics, said the results demonstrate that "landmark progress has emerged in autonomous surgical systems" in recent months. The case for autonomous interventions is indeed "strengthening," but are we on the brink of breakthrough in autonomous robotic surgery? Yes and no, he answered. "The employed SRT-H system presented capability for error correction and generalization, which may lead to scalability," Haidegger said. "This is major. A first baby-step." The current experiments, however, "only represent embryonic advancement in the super-complex domain of human surgery," he said, comparing the development of autonomous robotic surgery to that of self-driving cars. "In 2004, all participants failed in crossing the Mojave desert during the first DARPA challenge, yet by 2007, even the simulated urban environment was manageable for most of the systems. Yet, when this technology hit the road, significant shortcomings were revealed, starting with the incompleteness of road signs to changing weather conditions, and most importantly -- the unpredictability of other drivers. "Variability in live human surgery -- such as individual anatomy and pathology, hemorrhage, physiological tissue movement and unmodelled tissue properties -- limits immediate clinical deployment of an autonomous system." Meanwhile, a British expert who was not connected to the new study agreed that it "really highlights the art of the possible with AI and surgical robotics." Danail Stoyanov, professor of robot vision at University College London's Department of Computer Science and co-director of the UCL Hawkes Institute, told UPI the field of computer vision is making "incredible advances" for surgical video, adding that the availability of open robotic platforms for such research "make it possible to demonstrate surgical automation." He cautioned however, that "many other challenges remain to make this practical in real clinical use. Technically generalizing to clinical conditions remains very hard, and there are additional hurdles with medical device verification, safety, efficacy and, of course, cost and liability." JHU's Krieger similarly noted the current study merely provides "proof of concept. Before any clinical application, we need extensive additional testing and regulatory approval to ensure patient safety remains the top priority." That being said, the immediate next step is to "train and test the system on more types of surgeries and expand its capabilities to perform complete autonomous surgeries from start to finish. "Currently, we've demonstrated success with a lengthy phase of gallbladder removal, but we want to broaden the system's surgical repertoire" to include procedures that would benefit from the robot's "consistent precision and ability to operate in challenging conditions where human factors like fatigue or tremor might be limiting factors," Krieger said.
